Gladstone in the News
The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.
Are we on the cusp of curing HIV/AIDS? The Gladstone Institutes joins with leaders from CIRM, UCSF and others to engage the community in an interactive forum on cure research on October 1.
Gladstone scientists have come a step closer to being able to repair the damage done by heart attacks, using a “cocktail of genes” to transform scar tissue into working heart muscles.
Researchers from the Gladstone Institutes in San Francisco found that injecting a therapy of genes into dead heart cells has promising implications for restarting the cells, based on studies done in mice and human cells in a lab.
Gladstone scientists report that they've transformed one kind of human heart cell into another in laboratory experiments, a promising development in the bid to find ways to repair damage from heart attacks.
Researchers have found a way to genetically reprogram scar tissue in the heart to make it behave like muscle tissue.
Scarred heart tissue can be transformed into beating cells using a cocktail of five genes, according to a new study.
Gladstone researchers performed the feat using human cells in a laboratory dish.
Heart disease, a leading cause of death in the U.S., costs billions, literally, in terms of services, medications, and lost productivity. Now, researchers have developed a new technique that “personalizes” treatment for those suffering from heart disease — a gene therapy approach that would be able to convert cells into heart muscle cells.
Professor Helps Develop pE-MAP Technique That Allows Scientists To Predict Effect of Enzyme Mutations
A research team led by Nevan Krogan, PhD, of Gladstone Institutes and the University of California, San Francisco (UCSF); Craig Kaplan, PhD, of Texas A&M University; and Christine Guthrie, PhD, a UCSF Professor, has created a new technique called the point mutant E-MAP approach (pE-MAP) to predict how an enzyme behaves, and what happens when this process is disrupted, by mapping thousands of interactions among an enzyme’s many moving parts.
Gladstone Investigator Nevan Krogan, PhD, is named new director of the California Institute for Quantitative Biosciences (QB3).